Blood Coagulation Factor Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMRMOA5146)
◆英語タイトル:Blood Coagulation Factor Inhibitors -Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMRMOA5146
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:25以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[Blood Coagulation Factor Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)]についてメールでお問い合わせはこちら
*** レポート概要(サマリー)***

DelveInsight’s,“Blood Coagulation Factor Inhibitors-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Blood Coagulation Factor Inhibitors. This report provides information on the therapeutic development based on the Blood Coagulation Factor Inhibitors dealing with mechanism of action, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated mechanism of action.


• The report provides a snapshot of the global therapeutic landscape of Blood Coagulation Factor Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Blood Coagulation Factor Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Blood Coagulation Factor Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

*** レポート目次(コンテンツ)***

• Blood Coagulation Factor Inhibitors Overview
• Blood Coagulation Factor Inhibitors Disease Associated
• Blood Coagulation Factor Inhibitors Pipeline Therapeutics
• Blood Coagulation Factor Inhibitors Therapeutics under Development by Companies
• Blood Coagulation Factor Inhibitors Late Stage Products (Filed and Phase III)
• Comparative Analysis
• Blood Coagulation Factor Inhibitors Mid Clinical Stage Products (Phase II)
• Comparative Analysis
• Blood Coagulation Factor Inhibitors Early Clinical Stage Products (Phase I and IND Filed)
• Comparative Analysis
• Blood Coagulation Factor Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Blood Coagulation Factor Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Blood Coagulation Factor Inhibitors – Discontinued Products
• Blood Coagulation Factor Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Blood Coagulation Factor Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

• Number of Products under Development for Blood Coagulation Factor Inhibitors by Therapy Area, 2015
• Number of Products under Development for Blood Coagulation Factor Inhibitors, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Blood Coagulation Factor Inhibitors Assessment by Monotherapy Products
• Blood Coagulation Factor Inhibitors Assessment by Combination Products
• Blood Coagulation Factor Inhibitors Assessment by Route of Administration
• Blood Coagulation Factor Inhibitors Assessment by Stage and Route of Administration
• Blood Coagulation Factor Inhibitors Assessment by Molecule Type
• Blood Coagulation Factor Inhibitors Assessment by Stage and Molecule Type
• Blood Coagulation Factor Inhibitors Therapeutics – Discontinued Products
• Blood Coagulation Factor Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2015

• Number of Products under Development for Blood Coagulation Factor Inhibitors by Therapy Area, 2015
• Number of Products under Development for Blood Coagulation Factor Inhibitors, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Blood Coagulation Factor Inhibitors Assessment by Monotherapy Products
• Blood Coagulation Factor Inhibitors Assessment by Combination Products
• Blood Coagulation Factor Inhibitors Assessment by Route of Administration
• Blood Coagulation Factor Inhibitors Assessment by Stage and Route of Administration
• Blood Coagulation Factor Inhibitors Assessment by Molecule Type
• Blood Coagulation Factor Inhibitors Assessment by Stage and Molecule Type

*** レポートのキーワード ***

薬剤、医薬品、製薬企業、試験、作用機序(MOA)、パイプライン、開発

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 脊椎固定装置の世界市場
    Spine-Related Disorders And Deformities Are Treated Using Spinal Fusion Devices. Disorders Such As Spinal Stenosis And Lumbar Degenerative Spondylolisthesis Are Caused Due To The Degeneration Of Intervertebral Disc, Deformity, Tumors, And Trauma. Implant Systems Equipped With Specially Designed Spin …
  • 分子診断分析装置・試薬のアジア市場
    This new 17-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market d …
  • cFMSキナーゼ阻害薬のパイプライン・インサイト2018
    SUMMARY DelveInsight’s, “cFMS Kinase Inhibitors-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the cFMS Kinase Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Disco …
  • ナイジェリアのカードと決済市場(マーケット最新情報)
    This report is the result of Timetric’s extensive market research covering the cards and payments industry in Nigeria. It contains detailed data on market dynamics along with latest industry happenings, industry players in Nigeria. "Nigeria Cards and Payments: Market Update" provides a top-level ove …
  • SD-WANルーターの世界市場
    SD-WAN Router Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, …
  • 世界及び中国の融氷液市場2016
    The 'Global and Chinese De-Icing Fluid Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global De-Icing Fluid industry with a focus on the Chinese market. The report provides key statistics on the market status of the De-Icing Fluid manufac …
  • 虚血再潅流障害(Ischemia Reperfusion Injury):治療薬開発パイプライン動向2018
    SUMMARY DelveInsight’s, “ Ischemia Reperfusion Injury-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Ischemia Reperfusion Injury. The DelveInsight’sReport covers the product profiles in various stages of development inclu …
  • アルミニウムダイカスト機器の世界市場:販売動向2018
    This report studies the global Aluminium Die Casting Machinery market status and forecast, categorizes the global Aluminium Die Casting Machinery market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, …
  • アルミニウムパイプ及び管市場:リトアニア(市場規模、動向、予測(~2018))
    This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for aluminium pipes and tubes in Lithuania. The research includes historic market data from 2007 to 2013 and forecasts until 2018 which makes the report an invaluable resource for in …
  • 3W Power S.A. (3W9)(電力分野):企業M&A動向
    Summary 3W Power S.A. (3W Power), formerly, 3W Power Holdings S.A., is a provider of power electronic solutions and related services. It is a holding company of AEG Power Solutions Group. (AEG Power). The company's products and services are related to power conversion and power controlling. AEG Powe …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMRMOA5146 )"Blood Coagulation Factor Inhibitors:阻害薬のグローバル市場2015(薬開発、治験動向)" (英文:Blood Coagulation Factor Inhibitors -Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。